JUPITER NEUROSCIENCES, INC. (JUNS) Form 8-K — Aug 24, 2026
Jupiter Neurosciences (JUNS) entered into a Securities Purchase Agreement on August 21, 2026 for a registered direct offering of 307,692 shares of common stock at $6.50 per share, for aggregate gross proceeds of approximately $2.0 million before fees, with closing expected on or about August 24, 2026 off its effective Form S-3 shelf (File No. 333-295085). D. Boral Capital LLC is acting as placement agent for a 7.0% cash fee plus expense reimbursement, with legal fees capped at $75,000.
Key figures
- Gross Proceeds
- 2000000
- Offering Price
- 6.5
- Shares Offered
- 307692
- Lockup period days
- 30
- Yorkville shares sold
- 107920
- Placement agent fee pct
- 7
- Yorkville price formula
- 97% of lowest daily VWAP over three consecutive trading days
- Issuance standstill days
- 30
- Yorkville sepa capacity usd
- 20000000
- Yorkville gross proceeds usd
- 851194
- Beneficial ownership limitation
- 4.99% (or 9.99% at purchaser election)
- Placement agent expense cap usd
- 75000
- Pre funded warrant exercise price
- 0.0001
Price after filing
Close on the filing date to close N calendar days later (from $5.66). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.